Ellen Herlaar

1.3k total citations
8 papers, 699 citations indexed

About

Ellen Herlaar is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Ellen Herlaar has authored 8 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Ellen Herlaar's work include Mast cells and histamine (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Ellen Herlaar is often cited by papers focused on Mast cells and histamine (4 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Ellen Herlaar collaborates with scholars based in United Kingdom, United States and Australia. Ellen Herlaar's co-authors include Zarin Brown, Victor Nurcombe, John K. Heath, Esteban S. Masuda, Sylvia Braselmann, Donald G. Payan, Rajinder Singh, Victoria M. Taylor, Gary R. Burleson and Andrew Nelson and has published in prestigious journals such as Development, Journal of Allergy and Clinical Immunology and Transplantation.

In The Last Decade

Ellen Herlaar

8 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Herlaar United Kingdom	6	324	228	104	75	71	8	699
Michi Tanaka Japan	14	232 0.7×	147 0.6×	107 1.0×	55 0.7×	106 1.5×	25	959
Hidehiko Kikuchi Japan	20	553 1.7×	307 1.3×	174 1.7×	56 0.7×	100 1.4×	81	1.1k
Mark F. Lawson United Kingdom	10	490 1.5×	334 1.5×	102 1.0×	166 2.2×	59 0.8×	12	990
Arthur Brouillet France	18	295 0.9×	199 0.9×	64 0.6×	60 0.8×	58 0.8×	23	723
Emmanuelle Rollet‐Labelle Canada	18	544 1.7×	386 1.7×	73 0.7×	95 1.3×	61 0.9×	27	1.0k
Gordon R. Pfeiffer United States	11	321 1.0×	93 0.4×	92 0.9×	53 0.7×	47 0.7×	12	617
R Mosselmans Belgium	12	484 1.5×	219 1.0×	139 1.3×	74 1.0×	107 1.5×	16	966
B Salh Canada	14	627 1.9×	210 0.9×	131 1.3×	104 1.4×	123 1.7×	28	1000
Patrícia Dillenburg-Pilla Brazil	9	414 1.3×	161 0.7×	133 1.3×	86 1.1×	35 0.5×	14	851
Greg Dietsch United States	8	200 0.6×	271 1.2×	47 0.5×	65 0.9×	49 0.7×	16	709

Countries citing papers authored by Ellen Herlaar

Since Specialization

Citations

This map shows the geographic impact of Ellen Herlaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Herlaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Herlaar more than expected).

Fields of papers citing papers by Ellen Herlaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Herlaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Herlaar. The network helps show where Ellen Herlaar may publish in the future.

Co-authorship network of co-authors of Ellen Herlaar

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Herlaar. A scholar is included among the top collaborators of Ellen Herlaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Herlaar. Ellen Herlaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Li, Hui, Catherine Sylvain, D. C. Carroll, et al.. (2015). Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling. Bioorganic & Medicinal Chemistry Letters. 25(10). 2122–2128. 5 indexed citations

2.

Deuse, T., Grant Hoyt, Johannes A. Govaert, et al.. (2008). Novel Immunosuppression. Transplantation. 85(6). 885–892. 28 indexed citations

3.

Zhu, Yanhong, Ellen Herlaar, Esteban S. Masuda, et al.. (2007). Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406. Toxicology and Applied Pharmacology. 221(3). 268–277. 35 indexed citations

4.

Herlaar, Ellen, et al.. (2006). Identification of the Syk kinase inhibitor R112 by a human mast cell screen. Journal of Allergy and Clinical Immunology. 118(3). 749–755. 64 indexed citations

5.

Herlaar, Ellen & Zarin Brown. (1999). p38 MAPK signalling cascades in inflammatory disease. Molecular Medicine Today. 5(10). 439–447. 490 indexed citations

6.

Hill, Sandra J., et al.. (1999). Homologous Human and Murine Antisense Oligonucleotides Targeting Stat6 : Functional Effects on Germline C ε Transcript. American Journal of Respiratory Cell and Molecular Biology. 21(6). 728–737. 20 indexed citations

7.

Herlaar, Ellen. (1999). p38 MARK signaling cascades in inflammatory disease.. Medical Entomology and Zoology. 5. 439–447. 1 indexed citations

8.

Nurcombe, Victor, et al.. (1992). MK: a pluripotential embryonic stem-cell-derived neuroregulatory factor. Development. 116(4). 1175–1183. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact